John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q3 2024)
As of Sep 30, 2024, the Ariel Appreciation Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 13, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2024, the filing reported:
Increases - Allstate Corporation (The), Affiliated Managers Group, Inc., APA Corporation, Bio-Rad Laboratories, Inc., BorgWarner Inc., and 20 more
Reductions - ADT Inc., AFLAC Incorporated, Adtalem Global Education Inc., Axalta, Bank of America Corporation, and 73 more
Complete Exits - Evercore Inc., Patterson Companies, Inc., Stericycle, Inc., Truist Financial Corporation, U.S. Bancorp, and 4 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2024
|
ADT
ADT Inc.
|
Sell |
-1,244,311
|
|
Q3 2024
|
AFL
AFLAC Incorporated
|
Sell |
-155,572
|
|
Q3 2024
|
ALL
Allstate Corporation (The)
|
Buy |
+20,623
|
|
Q3 2024
|
AMG
Affiliated Managers Group, Inc.
|
Buy |
+9,344
|
|
Q3 2024
|
APA
APA Corporation
|
Buy |
+30,784
|
|
Q3 2024
|
ATGE
Adtalem Global Education Inc.
|
Sell |
-689,374
|
|
Q3 2024
|
AXTA
Axalta
|
Sell |
-72,876
|
|
Q3 2024
|
BAC
Bank of America Corporation
|
Sell |
-2,325
|
|
Q3 2024
|
BAP
Credicorp
|
Sell |
-104,512
|
|
Q3 2024
|
BCO
Brinks Company (The)
|
Sell |
-129,368
|
|
Q3 2024
|
BIDU
Baidu, Inc.
|
Sell |
-718,141
|
|
Q3 2024
|
BIO
Bio-Rad Laboratories, Inc.
|
Buy |
+274,508
|
|
Q3 2024
|
BMY
Bristol-Myers Squibb Company
|
Sell |
-276,697
|
|
Q3 2024
|
BOKF
BOK Financial Corporation
|
Sell |
-55,435
|
|
Q3 2024
|
BRC
Brady Corporation
|
Sell |
-275,390
|
|
Q3 2024
|
BWA
BorgWarner Inc.
|
Buy |
+138,024
|
|
Q3 2024
|
BYD
Boyd Gaming Corporation
|
Buy |
+153,446
|
|
Q3 2024
|
CBRE
CBRE Group Inc
|
Sell |
-69,487
|
|
Q3 2024
|
CG
The Carlyle Group Inc.
|
Buy |
+150,672
|
|
Q3 2024
|
CHKP
Check Point
|
Sell |
-136,577
|
|
Q3 2024
|
CLB
Core Laboratories Inc.
|
Sell |
-247,040
|
|
Q3 2024
|
CMA
Comerica Incorporated
|
Buy - Position Entry |
+304,481
|
|
Q3 2024
|
CNH
CNH Industrial
|
Sell |
-582,665
|
|
Q3 2024
|
COF
Capital One Financial Corporati
|
Sell |
-123,233
|
|
Q3 2024
|
CRL
Charles River Laboratories Inte
|
Sell |
-8,450
|
|
Q3 2024
|
CVS
CVS Health Corporation
|
Sell |
-52,277
|
|
Q3 2024
|
CVX
Chevron Corporation
|
Buy |
+6,226
|
|
Q3 2024
|
DHI
D.R. Horton, Inc.
|
Sell |
-24,998
|
|
Q3 2024
|
DNB
Dun & Bradstreet Holdings, Inc.
|
Sell |
-246,027
|
|
Q3 2024
|
DVA
DaVita Inc.
|
Sell |
-114,776
|
Page 1 of 4